Literature DB >> 26566103

Aldosterone and Left Ventricular Remodeling.

C Catena1, G Colussi1, G Brosolo1, M Novello1, L A Sechi1.   

Abstract

Experimental and clinical evidence obtained in the last 2 decades clearly indicates that protracted exposure to inappropriately elevated aldosterone levels causes significant changes in left ventricular structure and function. Animal studies have demonstrated that aldosterone induces myocardial inflammatory changes and fibrosis in the presence of a high salt diet. Moreover, the effects of aldosterone on the heart have been investigated in different clinical conditions. These conditions include systolic and diastolic heart failure, essential hypertension, and primary aldosteronism that offers a unique clinical model to study the cardiac effects of excess aldosterone because these effects are isolated from those of the renin-angiotensin axis. A relatively clear picture is emerging from these studies with regard to aldosterone-related changes in left ventricular mass and geometry. Conversely, no direct effect of aldosterone on left ventricular diastolic function can be demonstrated and improvement of diastolic function obtained in some studies that have employed mineralocorticoid receptor blockers could result from left ventricular mass reduction. Animal experiments demonstrate that effects of aldosterone on the left ventricle require high salt intake to occur, but the evidence of this contribution of salt to aldosterone-induced cardiac changes in humans remains weaker and needs further research. The article reviews the results of clinical studies addressing the role of aldosterone in regulation of LV remodeling and diastolic function, and focuses on the possible relevance of salt intake. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26566103     DOI: 10.1055/s-0035-1565055

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  15 in total

Review 1.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 2.  The role of arterial hypertension in development heart failure with preserved ejection fraction: just a risk factor or something more?

Authors:  Marijana Tadic; Cesare Cuspidi; Athanasios Frydas; Guido Grassi
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

3.  Lipid profile and left ventricular geometry pattern in obese children.

Authors:  Bojko Bjelakovic; Claudia Stefanutti; Vladimir Vukovic; Nebojsa Kavaric; Ljiljana Saranac; Aleksandra Klisic; Stevo Lukic; Sanja Stankovic; Maja Jovic; Sergej Prijic; Marko Bjelakovic; Maciej Banach
Journal:  Lipids Health Dis       Date:  2020-05-26       Impact factor: 3.876

4.  Effects of hypoestrogenism and/or hyperaldosteronism on myocardial remodeling in female mice.

Authors:  Patricia Rouet-Benzineb; Régine Merval; Evelyne Polidano
Journal:  Physiol Rep       Date:  2018-11

5.  Plasma renin levels are associated with cardiac function in primary adrenal insufficiency.

Authors:  Peter Wolf; Hannes Beiglböck; Paul Fellinger; Lorenz Pfleger; Stefan Aschauer; Alois Gessl; Rodrig Marculescu; Siegfried Trattnig; Alexandra Kautzky-Willer; Anton Luger; Yvonne Winhofer; Martin Krššák; Michael Krebs
Journal:  Endocrine       Date:  2019-06-08       Impact factor: 3.633

6.  Dilated cardiomyopathy and aldosteronoma: a causal link?

Authors:  Jiyu Zhang; Jin Yang; Yueliang Li
Journal:  ESC Heart Fail       Date:  2019-12-19

7.  Zi Shen Huo Luo Formula Enhances the Therapeutic Effects of Angiotensin-Converting Enzyme Inhibitors on Hypertensive Left Ventricular Hypertrophy by Interfering With Aldosterone Breakthrough and Affecting Caveolin-1/Mineralocorticoid Receptor Colocalization and Downstream Extracellular Signal-Regulated Kinase Signaling.

Authors:  Xiaotong Song; Yue Zhao; Shijun Wang; Yuan Wang; Qian Chen; Haijun Zhao; Hua Wang; Sheng Tian; Huayun Yu; Zhichun Wu
Journal:  Front Pharmacol       Date:  2020-04-03       Impact factor: 5.810

8.  Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease.

Authors:  Alberto Galizzi; Mara Bagardi; Angelica Stranieri; Anna Maria Zanaboni; Dario Malchiodi; Vitaliano Borromeo; Paola Giuseppina Brambilla; Chiara Locatelli
Journal:  BMC Vet Res       Date:  2021-01-07       Impact factor: 2.741

Review 9.  Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage?

Authors:  Cristiana Catena; Gian Luca Colussi; Gabriele Brosolo; Nicole Bertin; Marileda Novello; Andrea Palomba; Leonardo A Sechi
Journal:  Int J Endocrinol       Date:  2017-09-19       Impact factor: 3.257

10.  FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis.

Authors:  Ineke Böckmann; Jonas Lischka; Beatrice Richter; Jennifer Deppe; Anja Rahn; Dagmar-Christiane Fischer; Jörg Heineke; Dieter Haffner; Maren Leifheit-Nestler
Journal:  Int J Mol Sci       Date:  2019-09-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.